The Burden of Attention-Deficit/Hyperactivity Disorder in Adults: A Real-World Linked Data Study Psychiatrist.com 2023
Lee Lulu, Arunajada Srikesh, Mikl Jaromir, Erensen Jennifer, Goodman David W. Prim Care Companion CNS Disorder 2023
This study analyzed linked data from National Health and Wellness Survey and claims to assess the differences in patient characteristics and outcomes, including health-related quality of life (HRQoL), work productivity and activity impairment, and health care resource utilization (HRU) and associated costs by comparing ADHD patients treated with either IR or ER and those unmedicated for ADHD versus ER + IR.
Conclusion: Patients with ADHD treated with longer duration of action formulations (extended-release plus an immediate booster in the afternoon) had substantially better economic outcomes versus shorter duration of formulation or unmedicated groups, offering potential cost savings to the health care system and the patient.